◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Renascience Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022
+Operating Income -178.8M -252.3M -333.9M -210.8M
Operating Margin % 99.9% 100.2% 100.0% 87.2%
Non Operating Income 1.1M 460,000 31,000 63,000
Non Operating Expenses 1.3M -- -- 31.0M
+Ordinary Income -179.0M -251.9M -333.8M -241.8M
Revenue Growth % 28.9% 24.6% -38.1% --
Income Before Taxes 143.8M -256.4M -333.8M -253.1M
Income Taxes 30.3M 2.0M 2.0M 1.2M
+Net Income 113.4M -258.3M -335.8M -254.3M
Net Margin % -63.4% 102.6% 100.6% 105.2%
Eps 8.92 -20.32 -26.42 -22.33
Depreciation Amortization 62,000 1.8M 1.4M 3.1M
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022
Cash And Deposits 1.8B 2.0B 2.2B 2.4B
Current Assets 1.9B 2.1B 2.3B 2.4B
Property Plant Equipment -- -- 4.3M 3.6M
Noncurrent Assets 110,000 2.4M 7.5M 9.9M
Total Assets 1.9B 2.1B 2.3B 2.4B
Current Liabilities 151.2M 126.0M 100.2M 37.9M
Total Liabilities 151.2M 482.1M 409.8M 237.2M
Retained Earnings -835.1M -948.5M -690.1M -354.3M
Total Equity 1.7B 1.6B 1.9B 2.2B
Equity Ratio 0.92 0.77 0.82 0.90
Book Value Per Share 135.32 126.40 146.72 173.14
Num Employees 3.00 4.00 3.00 4.00
Roe 0.07 -- -- --
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022
Operating Cash Flow -176.3M -230.5M -284.6M -230.5M
Investing Cash Flow 382.1M -1.6M 232,000 -296,000
Financing Cash Flow -52.2M 46.5M 110.4M 1.6B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...